Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
CTSO — Cytosorbents Corporation
NASDAQ
FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 13, 2025
REVENUE
$9.5M -1.4%
NET MARGIN
-33.4% -53.7 PTS
EPS
-$0.05 -260.8%
FREE CASH FLOW
-$2.6M -67.7%

No summary has been written for this call yet.